Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Desconocido
ClinicalTrials.gov
Multicenter Prospective Observational and Epidemiological Registry for Patients With Intestinal Failure Due to Short Bowel Syndrome, in Latin America
OBSERVATIONAL
Inicio: 1 de jun de 2017
ID: NCT04976075
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Open-Label Extension, Efficacy and Safety Study of a Retinoic Acid Receptor Gamma (RARγ) Specific Agonist (Palovarotene) in the Treatment of Preosseous Flare-ups in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)
INTERVENTIONAL
Inicio: 9 de oct de 2014
ID: NCT02279095
Completado
Fase 3
ClinicalTrials.gov
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00157339
Desconocido
Fase 2
ClinicalTrials.gov
Randomised Phase II Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population (rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV).
INTERVENTIONAL
Inicio: 26 de jul de 2021
ID: NCT04983537
Completado
ClinicalTrials.gov
A Multi-center, Longitudinal, Observational Study of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease Progression
OBSERVATIONAL
Inicio: 1 de jun de 2011
ID: NCT01430494
Terminado
Fase 3
ClinicalTrials.gov
Open-Label, Long Term, Flexible Dose Study Of Safety, Tolerability, And Therapeutic Response In Patients With Parkinson's Disease.
INTERVENTIONAL
Inicio: 1 de ago de 2000
ID: NCT00036205
Completado
Fase 3
ClinicalTrials.gov
A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
INTERVENTIONAL
Inicio: 27 de ago de 2021
ID: NCT04950127
Completado
Fase 2
ClinicalTrials.gov
A Phase II Open-Label Extension Study of Patients Previously Enrolled in Study GA29350 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 30 de nov de 2016
ID: NCT02983227
Terminado
Fase 3
ClinicalTrials.gov
A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002 (IMPAHCT-FUL)
INTERVENTIONAL
Inicio: 2 de nov de 2022
ID: NCT05557942
Completado
ClinicalTrials.gov
Evaluation of an mHealth Intervention Using an Automated Text Message (SMS) Invitation System to Increase Participation in Mammography Screening Among Women Aged 50-69 Years in the Province of Santa Fe, Argentina
INTERVENTIONAL
Inicio: 5 de dic de 2021
ID: NCT06500936
Reclutando
Fase 2
ClinicalTrials.gov
A Randomized, Participant- and Investigator-blinded, Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LXE408 in Participants With Chronic Chagas Disease Without Severe Organ Dysfunction.
INTERVENTIONAL
Inicio: 28 de abr de 2025
ID: NCT06632600
Completado
Fase 4
ClinicalTrials.gov
Phase 4: Study of Ketamine Inhibition of Interleukin 6 in Hepatic Resections Requiring Temporary Porto-arterial Occlusion
INTERVENTIONAL
Inicio: 1 de jun de 2001
ID: NCT00978757
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 (ZACTIMA™) in Combination With Pemetrexed (Alimta®) Versus Pemetrexed Alone in Patients With Locally-Advanced or Metastatic NSCLC
INTERVENTIONAL
Inicio: 1 de ene de 2007
ID: NCT00418886
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Metmab Vs. Placebo in Combination With Either Bevacizumab + Platinum + Paclitaxel or Pemetrexed + Platinum in Patients With Untreated Stage IIIb or IV Non-Squamous NSCLC
INTERVENTIONAL
Inicio: 1 de abr de 2012
ID: NCT01496742
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) Versus Avonex® (Interferon β 1a) in Patients With Relapsing-Remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01064401
Terminado
Fase 3
ClinicalTrials.gov
A Randomised, Multicentre, Double-Blind, Placebo-Controlled Study Of Ambrisentan In Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
INTERVENTIONAL
Inicio: 1 de sept de 2013
ID: NCT01884675
Reclutando
Fase 2
ClinicalTrials.gov
A Phase I/II Randomized Multi-Cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors
INTERVENTIONAL
Inicio: 4 de mar de 2025
ID: NCT06796907
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults
INTERVENTIONAL
Inicio: 28 de nov de 2024
ID: NCT06687967
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants With Non-Segmental Vitiligo
INTERVENTIONAL
Inicio: 27 de nov de 2023
ID: NCT06113328
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 15 de may de 2008
ID: NCT00698828
Anterior
1
...
423
424
425
...
434
Siguiente
Filtros